Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruers

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Critical Reviews in Oncology/Hematology|February 24, 2007
Local radiofrequency ablation techniques for liver metastases of colorectal cancerJ Joosten, T Ruers
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2011
Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancerD Hompes, T Ruers
European Journal of Cancer (Oxford, England : 1990)|April 30, 2002
Treatment of liver metastases, an update on the possibilities and resultsT Ruers, R P Bleichrodt
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 26, 2011
Radiofrequency ablation as a treatment tool for liver metastases of colorectal originD Hompes, W Prevoo, T Ruers
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 30, 2005
Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastasesJ Joosten, G Jager, W Oyen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 19, 2008
Pulmonary resection of colorectal metastases in patients with or without a history of hepatic metastasesJ Joosten, J Bertholet, M Keemers-Gels, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 3, 2006
Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver diseaseE T Waas, Th Wobbes, T Ruers, et al.
The British Journal of Surgery|December 4, 2003
Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasisE T Waas, T Wobbes, R M L M Lomme, et al.
Biotechniques|February 23, 2000
New protocol for DNA extraction of stoolB M Machiels, T Ruers, M Lindhout, et al.
ESMO Open|July 24, 2025
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)J Seligmann, T Koessler, M Mauer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|February 24, 2007
Local radiofrequency ablation techniques for liver metastases of colorectal cancerJ Joosten, T Ruers
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2011
Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancerD Hompes, T Ruers
European Journal of Cancer (Oxford, England : 1990)|April 30, 2002
Treatment of liver metastases, an update on the possibilities and resultsT Ruers, R P Bleichrodt
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 26, 2011
Radiofrequency ablation as a treatment tool for liver metastases of colorectal originD Hompes, W Prevoo, T Ruers
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 30, 2005
Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastasesJ Joosten, G Jager, W Oyen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 19, 2008
Pulmonary resection of colorectal metastases in patients with or without a history of hepatic metastasesJ Joosten, J Bertholet, M Keemers-Gels, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 3, 2006
Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver diseaseE T Waas, Th Wobbes, T Ruers, et al.
The British Journal of Surgery|December 4, 2003
Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasisE T Waas, T Wobbes, R M L M Lomme, et al.
Biotechniques|February 23, 2000
New protocol for DNA extraction of stoolB M Machiels, T Ruers, M Lindhout, et al.
ESMO Open|July 24, 2025
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)J Seligmann, T Koessler, M Mauer, et al.
Pageof 2